TY - JOUR
T1 - Association of Skilled Nursing Facility Participation in a Bundled Payment Model with Institutional Spending for Joint Replacement Surgery
AU - Barnett, Michael L.
AU - Joynt Maddox, Karen E.
AU - Orav, E. John
AU - Grabowski, David C.
AU - Epstein, Arnold M.
N1 - Funding Information:
reports receipt of support from the National Institute on Aging (NIA) of the National Institutes of Health (NIH), Agency for Healthcare Research & Quality (AHRQ), and the Retirement Research Foundation. Dr Joynt Maddox reported receipt of grants from National Institute on Aging (NIA) during the conduct of the study and the National Heart, Lung, and Blood Institute; other from the US Department of Health and Human Services; and support from the Commonwealth Fund outside the submitted work. Dr Grabowski reported receipt of grants from the NIA during the conduct of the study and grants from the NIA, AHRQ, the Warren Alpert Foundation, the Arnold Foundation, and the Donaghue Foundation; and personal fees from naviHealth, the Analysis Group, Abt Associates, the Medicare Payment Advisory Commission, Research Triangle Institutes, and Compass Lexecon outside the submitted work. No other disclosures were reported.
Funding Information:
Funding/Support: This work was supported by grants from the NIA/NIH (K23 AG058806-01; to Dr Barnett) and R01 AG060935-01 (to Drs Epstein, Grabowski, Orav, and Joynt Maddox).
Publisher Copyright:
Copyright © 2020 JAMA - Journal of the American Medical Association.
PY - 2020/11/10
Y1 - 2020/11/10
N2 - Importance: Medicare recently concluded a national voluntary payment demonstration, Bundled Payments for Care Improvement (BPCI) model 3, in which skilled nursing facilities (SNFs) assumed accountability for patients' Medicare spending for 90 days from initial SNF admission. There is little evidence on outcomes associated with this novel payment model. Objective: To evaluate the association of BPCI model 3 with spending, health care utilization, and patient outcomes for Medicare beneficiaries undergoing lower extremity joint replacement (LEJR). Design, Setting, and Participants: Observational difference-in-difference analysis using Medicare claims from 2013-2017 to evaluate the association of BPCI model 3 with outcomes for 80648 patients undergoing LEJR. The preintervention period was from January 2013 through September 2013, which was 9 months prior to enrollment of the first BPCI cohort. The postintervention period extended from 3 months post-BPCI enrollment for each SNF through December 2017. BPCI SNFs were matched with control SNFs using propensity score matching on 2013 SNF characteristics. Exposures: Admission to a BPCI model 3-participating SNF. Main Outcomes and Measures: The primary outcome was institutional spending, a combination of postacute care and hospital Medicare-allowed payments. Additional outcomes included other categories of spending, changes in case mix, admission volume, home health use, length of stay, and hospital use within 90 days of SNF admission. Results: There were 448 BPCI SNFs with 18870 LEJR episodes among 16837 patients (mean [SD] age, 77.5 [9.4] years; 12173 [72.3%] women) matched with 1958 control SNFs with 72005 LEJR episodes among 63811 patients (mean [SD] age, 77.6 [9.4] years; 46072 [72.2%] women) in the preintervention and postintervention periods. Seventy-nine percent of matched BPCI SNFs were for-profit facilities, 85% were located in an urban area, and 85% were part of a larger corporate chain. There were no systematic changes in patient case mix or episode volume between BPCI-participating SNFs and controls during the program. Institutional spending decreased from $17956 to $15746 in BPCI SNFs and from $17765 to $16563 in matched controls, a differential decrease of 5.6% (-$1008 [95% CI,-$1603 to-$414]; P <.001). This decrease was related to a decline in SNF days per beneficiary (from 26.2 to 21.3 days in BPCI SNFs and from 26.3 to 23.4 days in matched controls; differential change,-2.0 days [95% CI,-2.9 to-1.1]). There was no significant change in mortality or 90-day readmissions. Conclusions and Relevance: Among Medicare patients undergoing lower extremity joint replacement from 2013-2017, the BPCI model 3 was significantly associated with a decrease in mean institutional spending on episodes initiated by admission to SNFs. Further research is needed to assess bundled payments in other clinical contexts..
AB - Importance: Medicare recently concluded a national voluntary payment demonstration, Bundled Payments for Care Improvement (BPCI) model 3, in which skilled nursing facilities (SNFs) assumed accountability for patients' Medicare spending for 90 days from initial SNF admission. There is little evidence on outcomes associated with this novel payment model. Objective: To evaluate the association of BPCI model 3 with spending, health care utilization, and patient outcomes for Medicare beneficiaries undergoing lower extremity joint replacement (LEJR). Design, Setting, and Participants: Observational difference-in-difference analysis using Medicare claims from 2013-2017 to evaluate the association of BPCI model 3 with outcomes for 80648 patients undergoing LEJR. The preintervention period was from January 2013 through September 2013, which was 9 months prior to enrollment of the first BPCI cohort. The postintervention period extended from 3 months post-BPCI enrollment for each SNF through December 2017. BPCI SNFs were matched with control SNFs using propensity score matching on 2013 SNF characteristics. Exposures: Admission to a BPCI model 3-participating SNF. Main Outcomes and Measures: The primary outcome was institutional spending, a combination of postacute care and hospital Medicare-allowed payments. Additional outcomes included other categories of spending, changes in case mix, admission volume, home health use, length of stay, and hospital use within 90 days of SNF admission. Results: There were 448 BPCI SNFs with 18870 LEJR episodes among 16837 patients (mean [SD] age, 77.5 [9.4] years; 12173 [72.3%] women) matched with 1958 control SNFs with 72005 LEJR episodes among 63811 patients (mean [SD] age, 77.6 [9.4] years; 46072 [72.2%] women) in the preintervention and postintervention periods. Seventy-nine percent of matched BPCI SNFs were for-profit facilities, 85% were located in an urban area, and 85% were part of a larger corporate chain. There were no systematic changes in patient case mix or episode volume between BPCI-participating SNFs and controls during the program. Institutional spending decreased from $17956 to $15746 in BPCI SNFs and from $17765 to $16563 in matched controls, a differential decrease of 5.6% (-$1008 [95% CI,-$1603 to-$414]; P <.001). This decrease was related to a decline in SNF days per beneficiary (from 26.2 to 21.3 days in BPCI SNFs and from 26.3 to 23.4 days in matched controls; differential change,-2.0 days [95% CI,-2.9 to-1.1]). There was no significant change in mortality or 90-day readmissions. Conclusions and Relevance: Among Medicare patients undergoing lower extremity joint replacement from 2013-2017, the BPCI model 3 was significantly associated with a decrease in mean institutional spending on episodes initiated by admission to SNFs. Further research is needed to assess bundled payments in other clinical contexts..
UR - https://www.scopus.com/pages/publications/85095970897
U2 - 10.1001/jama.2020.19181
DO - 10.1001/jama.2020.19181
M3 - Article
C2 - 33170241
AN - SCOPUS:85095970897
SN - 0098-7484
VL - 324
SP - 1869
EP - 1877
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 18
ER -